SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
Hand-out
Press Releases
April 15, 2025

SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term side effects and impact on daily life compared with Pfizer-BioNTech mRNA vaccineFull results will be

bradford

The Bradford Era

Local & Social